Fuel Progress
Dive into the collective wisdom, insights, and strategies from experts in pharma and biotech.


Trending on OVN
01
Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard
May 12th • 5 mins read
02
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
May 25th • 5 mins read
03
04
Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring
Apr 20th • 8 mins read
05
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020
Apr 20th • 7 mins read
06

AI-powered real-world evidence: Strategically enhancing value and access
Aug 22nd • 5 mins read
Featured Articles





Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
May 6th • 18 mins read

Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
We are proud to announce the forthcoming publication of Voices of Oncology — a first-of-its-kind collection of expert perspectives from across the oncology ecosystem, arriving July 2025 in partnership with...

Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard
At the heart of the Oncology Voice Network (OVN) is a powerful mission: to unify oncology leaders across disciplines and accelerate the development of solutions that truly serve patients. Driving...

Introducing OncologyVoiceNetwork.com
A New Era of Insight, Collaboration, and Innovation in Oncology
We are proud to announce the official launch of OncologyVoiceNetwork.com — a next-generation media platform purpose-built to serve the evolving needs...